The Millionaire’s Secret: Consumption vs. Ownership Have you ever watched someone light a cigarette and thought, "There goes ₹15-₹20, literally up in smoke"? Most people see the health warning. Smart investors see the Cash Flow. We’ve all seen people burning their money away, one stick at a time. But have you ever thought about being on the other side of that cash register? In the stock market, while the world is obsessing over the "Warning labels," the elite investors are dissecting the Balance Sheet . Godfrey Phillips India (GODFRYPHLP) is currently a "Sleeping Giant" trading right near its 52-week low (~₹1,900) in March 2026. This isn’t a signal to panic; it’s an invitation to join the owners’ club. Instead of smoking away your savings, it’s time to own a piece of the profit-making machine. 🚀 The 4-Engine Multibagger Rocket Godfrey Phillips isn't just a tobacco company anymore; it’s a high-efficiency profit compounder. Here is why the future i...
SKF India Share Analysis 2025 — Complete Fundamental Review, Technical Outlook & Long-Term Multibagger Potential
Introduction
SKF India is one of the most advanced engineering and motion-technology companies in India. Its precision bearings, seals, lubrication systems and condition-monitoring solutions power critical sectors such as Electric Vehicles, Railways, Wind Energy, Industrial Automation, Passenger Vehicles and Commercial Vehicles.
The company’s financial quality is exceptional:
-
Zero debt
-
Strong cash reserves
-
ROCE consistently above 27–29%
-
High free cash flow
-
Global SKF R&D support
-
Sticky OEM relationships
In FY25, SKF restructured its automotive and industrial operations for strategic clarity. Because of this accounting change, the share price adjusted from around ₹5,000 to ~₹2,300, reflecting value split between two entities — not a business decline. All manufacturing, customers, cash reserves and R&D access remain intact.
SKF continues to operate as a stable high-quality compounding business.
Business Segments
Automotive Division (≈40% revenue)
Key products:
2W/3W bearings, PV/SUV hub bearings, CV bearings, EV high-speed bearings, seals and lubrication systems.
Growth drivers:
-
EV adoption
-
Premium SUV boom
-
OEM localisation
-
High-efficiency bearing demand
Expected growth: 10–12% CAGR
Industrial Division (≈60% revenue)
Key products:
Railway bearings (Vande Bharat, Metro), wind turbine bearings, industrial drives, AI/IoT condition monitoring, remanufacturing services.
Growth drivers:
-
Railway CAPEX expansion
-
Renewable wind energy
-
Industry 4.0 (smart factories)
-
Predictive maintenance
Expected growth: 8–10% CAGR
Deep Fundamental Analysis
1. Sticky & High-Quality Revenue
SKF supplies mission-critical components where OEMs require precision and reliability. Vendor switching is rare, making revenues stable and recurring.
2. Margins & Cash Flow Strength
EBITDA margins: 16–18%
Driven by premium EV bearings, industrial services and localisation.
SKF converts most profit into cash, resulting in:
-
Zero debt
-
₹1,200+ crore cash
-
Fully self-funded capex
3. Competitive Moat
Based on global R&D, advanced metallurgy, long OEM approval cycles and micron-level manufacturing accuracy. Almost impossible for new players to replicate.
4. Balanced Business Model
-
Automotive: volume + EV growth
-
Industrial: high margin + replacement demand
Ensures low cyclicality and stable earnings.
Fundamental Verdict
SKF India is a precision-engineering compounder with high ROCE, strong cash flow, sector tailwinds and undervalued stock price after restructuring.
Long-Term Growth Drivers
-
EV revolution → high-speed ceramic bearings
-
Railway modernization → Vande Bharat, Metro
-
Wind energy → large turbine bearings
-
Predictive maintenance → AI/IoT solutions
-
Remanufacturing → high-margin recurring service
Big tailwinds for the next 10 years.
Technical Analysis
CMP: ₹1,915–₹1,955
Trend:
Short-term weak, long-term structure intact.
Pattern:
Falling wedge (bullish reversal)
Support:
-
Strong: ₹1,920–₹1,940
-
Critical: ₹1,880–₹1,900
Resistance:
-
₹1,980–₹2,000
-
₹2,250 (major breakout)
-
₹2,500–₹2,800 (post-breakout targets)
Technical View:
RSI oversold → accumulation zone
Breakout above ₹2,250 → strong uptrend possible
Valuation
Post-restructure P/E: ~19×
Industry P/E: 25–38×
Fair Value Range:
₹3,500 – ₹3,800 (clear undervaluation)
Multibagger Potential (2025–2035)
Expected 10-Year Upside:
⭐ 7× – 12×
Driven by high ROCE, cash-rich balance sheet, EV + rail + wind growth and strong services revenue.
Not a hype stock — a quality-led compounding multibagger.
Price Targets
| Timeframe | Target |
|---|---|
| 1 Year | ₹2,800 – ₹3,200 |
| 3 Years | ₹6,000 – ₹7,000 |
| 5 Years | ₹9,500 – ₹10,500 |
| 10 Years | ₹20,000 – ₹25,000 |
Risks
-
Auto demand fluctuations
-
Railway project delays
-
Steel/raw material inflation
-
Forex impact
-
Global competition
Structural long-term story remains strong.
Final Verdict
✔ SKF India is a strong long-term BUY
-
Zero debt
-
High ROCE
-
Strong cash flow
-
Premium product leadership
-
Sector tailwinds
-
Undervalued starting point
Ideal allocation: 5–8%
Holding period: 5–10 years
Other Deep-Dive Blogs from TRRASS Think Tank
If you enjoyed this analysis, here are some of my previous research blogs you will love:
1. Top 5 PSU BANK STOCK
https://trrass.blogspot.com/2023/12/top-5-psu-banks-stock.html
2.Best stock potential to Multibagger link
https://trrass.blogspot.com/2023/12/best-stock-potential-to-multibagger.htm
3. Top 5 private sector bank
https://trrass.blogspot.com/2023/12/top-5-private-sector-bank-stock.html
4. Can this new IPO Stock Become a big multi-bagger ??
https://trrass.blogspot.com/2024/01/friends.html
5.ITC vs Godfrey Phillips: Which Stock Can Become a Multi-bagger in the Next 10 Years?
https://trrass.blogspot.com/2025/11/itc-vs-godfrey-phillips-which-stock-can.html
6.Anthem Biosciences 50X Potential? Full CRDMO Multibagger Analysis, Financials, Expansion & Long-Term Outlook
https://trrass.blogspot.com/2025/11/anthem-biosciences-crdmo-analysis-50x-potential.html
7.Themis Medicare Stock Analysis 2025: Can This Silent Pharma Player Become a Multi-bagger?
https://trrass.blogspot.com/2025/11/themis-medicare-stock-analysis-2025-multibagger-potential.html
If you found this analysis valuable, share it with someone who loves honest and high-conviction stock research.
TRRASS Think Tank delivers deep-dive fundamental insights, sector studies, and potential multi bagger stories backed by clear logic and clean data.
👉 Follow TRRASS Think Tank for more powerful, research-driven stock analyses every week.
👉 Want a deep dive on any specific stock? Drop a comment — I respond to everyone.
⚠️ Disclaimer
This blog is for educational and informational purposes only. It reflects personal analysis and opinions based on publicly available information. This is not investment advice. Please consult your financial advisor before making any investment decisions. Stock markets carry risks; invest responsibly.